Tuesday, March 17, 2026

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

Despite Tariff Relief, U.S. Inflation Fears Hit 44-Year High

Despite a 90-day tariff suspension, inflation fears rise, with consumer sentiment at its lowest since 1978, impacting economic growth.

NVIDIA’s Stock Takes a Dive Amid China’s Antitrust Investigation

NVIDIA's stock drops amid a Chinese antitrust probe, following allegations of failing to meet technology transfer obligations.

Tag: Hyundai Rotem

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.